Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 3.040
-0.200 (-6.17%)
Jul 28, 2025, 4:35 PM GMT+1
Proteome Sciences Revenue
In the year 2024, Proteome Sciences had annual revenue of 4.89M GBP, down -2.80%. Proteome Sciences had revenue of 2.67M in the half year ending December 31, 2024, a decrease of -41.15%.
Revenue
4.89M
Revenue Growth
-2.80%
P/S Ratio
1.84
Revenue / Employee
135.75K
Employees
36
Market Cap
8.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.89M | -141.00K | -2.80% |
| Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
| Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
| Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
| Dec 31, 2020 | 4.75M | 97.00K | 2.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Proteome Sciences News
- 5 weeks ago - AIM Market Roundup: Seascape Energy, Earnz, Directa Plus - The Armchair Trader
- 5 months ago - AIM Market Roundup: Proteome Sciences, UKRProduct, Staffline - The Armchair Trader